Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.
Dental fillings aren't a pleasant way to fix cavities but they're necessary to fill holes and prevent further damage. But now ...
For clinicians, managing recurrent aphthous stomatitis means looking beyond the ulcer to triggers and systemic links.
Everyday Health on MSN
Your Inflammatory Bowel Disease (IBD) Holiday Survival Guide: 6 Tips
Get tips from experts on navigating the holiday season with inflammatory bowel disease, including how to plan ahead and practice self-care.
A few weeks ago, at CultureCon, I discovered In Real LifeTimeless Hydrating Dew Gel-Cream. The formula is super lightweight, absorbs into your skin instantly, and leaves behind a plump, dewy finish ...
Verywell Health on MSN
9 Foods With More Prebiotics Than a Supplement
Whenever possible, getting prebiotic fiber from food is preferred over taking supplements. Learn which foods are high in fiber to maximize your gut health.
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Everyday Health on MSN
Is ‘Fibermaxxing’ Safe for Inflammatory Bowel Disease?
While increased fiber can help improve symptoms, ‘fibermaxxing’ — fitting as much fiber as possible into every meal — isn’t the best approach for Crohn’s or ulcerative colitis.
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? But is all of this concern warranted? For the answers, I turned to three board ...
To address the specific challenges faced by older adults with inflammatory bowel disease (IBD), UCSF Health created the UCSF ...
James Cook University (JCU) researchers have discovered that the same chemical compounds produced by mountain-top plants to help them survive climate change in North Queensland may also hold promise ...
AstraZeneca has returned to its longtime artificial intelligence partner Immunai with a new deal worth up to $85 million to advance a suitable target for a new inflammatory bowel disease (IBD) therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results